ZMYND8 is a primary HIF coactivator that mediates breast cancer progression

類似資料

• ZMYND8 acetylation mediates HIF-dependent breast cancer progression and metastasis
  著者:: Chen, Yan, 等
  出版事項: (2018)
• ZMYND8 expression in breast cancer cells blocks T-lymphocyte surveillance to promote tumor growth
  著者:: Wang, Yong, 等
  出版事項: (2020)
• CHD4 promotes breast cancer progression as a coactivator of hypoxia-inducible factors
  著者:: Wang, Yijie, 等
  出版事項: (2020)
• ZMYND8 protects breast cancer stem cells against oxidative stress and ferroptosis through activation of NRF2
  著者:: Maowu Luo, 等
  出版事項: (2024-03-01)
• Regulation of ZMYND8 to Treat Cancer
  著者:: Chen, Yun, 等
  出版事項: (2021)